Disease Management

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, highlighted recent developments and available treatments in myeloproliferative neoplasms care.

In this video, Laurie Keefer, PhD, Healio’s 2023 Allied Health Provider of the Year, underscores the importance of providing interventions to patients at the time of a GI diagnosis — not just when symptoms of depression or anxiety develop.

Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, discusses the unmet needs among patients with Huntington's disease and the clinicians who treat them.

Adam Margolius, MD, neurology specialist at Cleveland Clinic, discusses recent medications that have been effective in calming excessive movements caused by tardive dyskinesia.

As IOP decreases throughout the day, it is essential for clinicians to evaluate both morning and evening values to effectively monitor IOP-related diseases, according to research published in Cureus.

Huma Therapeutics announced that it has received class II clearance from the FDA for its disease management platform, which facilitates data collection from patients for self-management or remote assessment by health care providers.

DESTIN, Fla. — IgG4-related disease may be regarded as this century’s “greatest mimicker,” but upcoming therapies and discoveries are reasons for excitement, according to a speaker at the 2023 Congress of Clinical Rheumatology-East.

A recent study in Annals of Family Medicine confirmed the validity and reliability of a clinical tool in assessing burdens of COPD, type 2 diabetes and asthma.

Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.